EUVIMEDEUVIMED entdecken
Crossref

Identification of broad-spectrum inhibitors for the cryptic binding site of SARS-CoV-2 NSP1 across multiple variants using molecular dynamics simulation

Abhishek Lakhera, Saroj Kumar Panda, Sanjay Kumar, Parth Sarthi Sen Gupta iD

Journal of Molecular Modeling · 2026-11 · 32 (11)

DOI: 10.1007/s00894-026-07031-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Modeling, online erschienen am 30.10.2026. Verfasst von Abhishek Lakhera und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Biosciences and Bioengineering, D Y Patil International University (DYPIU), Akurdi, Pune, Maharashtra, 411044, India. Hauptthemen laut MEDLINE: Viral Nonstructural Proteins, Sorafenib, Antiviral Agents, SARS-CoV-2. Die Arbeit nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CONTEXT: Non-structural protein 1 (NSP1) is a critical viral virulence factor expressed early during SARS-CoV-2 infection that facilitates host immune evasion by supressing host gene expression through its interaction with the 40S ribosomal subunit. NSP1 occludes the mRNA entry channel, thereby inhibiting translation of host transcripts while selectively permitting viral mRNA translation. Recent advances in structural biology have revealed previously unrecognized cryptic binding pocket within NSP1, expanding the repertoire of viable drug targets. In this study, we systematically investigated an allosteric pocket of NSP1 as a novel intervention strategy to disrupt NSP1-mRNA interactions. Virtual screening of FDA-approved drugs identified sorafenib as a promising allosteric inhibitor. For the broad-spectrum efficacy evaluation, sorafenib inhibitory potential against a variety of clinically relevant NSP1 mutants was tested. Detailed molecular dynamics simulations of the wild-type and mutant systems showed that sorafenib binding leads to different conformational and dynamic changes, that result in protein stabilization. Residue-level fluctuation analyses indicated that sorafenib had relatively stable interactions within the allosteric pocket even in the presence of destabilizing mutations, suggesting resilience against mutation-driven resistance. We have identified allosteric targeting as a viable approach to blocking the functional role of NSP1 in host translation shutdown. Sorafenib emerges as a promising broad-spectrum NSP1 inhibitor for additional experimental testing and development of NSP1-directed antiviral therapeutics. METHODS: All FDA-approved drugs were first optimized using the semi-empirical PM6 method. The optimized structures were subsequently subjected to virtual screening against the cryptic binding site of NSP1 using AutoDock. MD simulations of the selected protein-ligand complexes were carried out using GROMACSv2023. Binding free energies were estimated using the MM/PBSA method and steered molecular dynamics simulations were performed to evaluate ligand dissociation. Post-MD trajectory analyses were performed using various built-in GROMACS tools and PyMol.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Viral Nonstructural ProteinsSorafenibAntiviral AgentsSARS-CoV-2Molecular Dynamics SimulationBinding SitesHumansAllosteric SiteMutationProtein Binding

Stichwörter der Autor:innen

AntiviralCryptic pocketMD simulationNSP1SARS-CoV-2Sorafenib

Substanzen

Viral Nonstructural ProteinsSorafenibAntiviral Agents

Autor:innen und Institutionen

  • School of Biosciences and Bioengineering, D Y Patil International University (DYPIU), Akurdi, Pune, Maharashtra, 411044, India.
  • Department of Chemistry and Biochemistry, University of Texas at Arlington, Arlington, TX, 76019, USA. saroj.panda2@uta.edu.
  • School of Engineering and Technology, National Forensic Sciences University, Near Police Bhawan, Sector 9, Gandhinagar, Gujarat, India.
  • School of Biosciences and Bioengineering, D Y Patil International University (DYPIU), Akurdi, Pune, Maharashtra, 411044, India. parth.gupta@dypiu.ac.in.

ORCID-Profile: Parth Sarthi Sen Gupta

Zitieren

APA

Lakhera, A., Panda, S. K., Kumar, S., & Gupta, P. S. S. (2026). Identification of broad-spectrum inhibitors for the cryptic binding site of SARS-CoV-2 NSP1 across multiple variants using molecular dynamics simulation. Journal of Molecular Modeling, 32(11). https://doi.org/10.1007/s00894-026-07031-9

Vancouver

Lakhera A, Panda SK, Kumar S, Gupta PSS. Identification of broad-spectrum inhibitors for the cryptic binding site of SARS-CoV-2 NSP1 across multiple variants using molecular dynamics simulation. Journal of Molecular Modeling. 2026;32(11). doi:10.1007/s00894-026-07031-9

BibTeX
@article{Lakhera2026,
  author = {Lakhera, Abhishek and Panda, Saroj Kumar and Kumar, Sanjay and Gupta, Parth Sarthi Sen},
  title = {Identification of broad-spectrum inhibitors for the cryptic binding site of SARS-CoV-2 NSP1 across multiple variants using molecular dynamics simulation},
  journal = {Journal of Molecular Modeling},
  year = {2026},
  volume = {32},
  number = {11},
  doi = {10.1007/s00894-026-07031-9}
}
Kostenlos starten →